α-Synuclein facilitates the toxicity of oxidized catechol metabolites: Implications for selective neurodegeneration in Parkinson’s disease  by Hasegawa, Takafumi et al.
FEBS Letters 580 (2006) 2147–2152a-Synuclein facilitates the toxicity of oxidized catechol metabolites:
Implications for selective neurodegeneration in Parkinson’s disease
Takafumi Hasegawaa, Michiko Matsuzaki-Kobayashia, Atsushi Takedaa,*, Naoto Sugenoa,
Akio Kikuchia, Katsutoshi Furukawab, George Perryc, Mark A. Smithc, Yasuto Itoyamaa
a Department of Neurology, Tohoku University School of Medicine, 1-1 Seiryomachi, Aobaku, Sendai, Miyagi 980-8574, Japan
b Geriatric and Complementary Medicine, Tohoku University School of Medicine, Sendai, Miyagi 980-8574, Japan
c Institute of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA
Received 20 February 2006; revised 2 March 2006; accepted 3 March 2006
Available online 15 March 2006
Edited by Barry HalliwellAbstract Free radicals, including dopamine (DA)-oxidized
metabolites, have long been implicated in pathogenesis of Par-
kinson’s disease (PD). However, the relationships between such
oxidative stresses and a-synuclein (a-S), a major constituent of
Lewy bodies, remain unknown. In this study, we established neu-
ronal cells that constitutively express a-S and tetracycline-regu-
lated tyrosinase. While tyrosinase overexpression induced
apoptosis, co-expression of wild type or A53T mutant human
a-S with tyrosinase further exacerbated cell death. In this pro-
cess, the formation of a-S oligomers and the reduction in mito-
chondrial membrane potential were demonstrated. This cellular
model may reconstitute the pathological metabolism of a-S in
the synucleinopathy and provide a useful tool to explore possible
pathomechanisms of nigral degeneration in PD.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Parkinson’s disease (PD) is characterized by preferential loss
of dopaminergic neurons in the substantia nigra (SN) and the
formation of intraneuronal ﬁbrillar inclusions called Lewy
bodies (LBs). Although the mechanisms underlying the selec-
tive neuronal loss in PD still remain elusive, numerous etiolog-
ical hypotheses have been proposed for PD including oxidative
stress, mitochondrial dysfunction, ubiquitin-proteasome dys-
function, and aberrant misfolded protein processing [1]. While
several genes have been linked to PD, a-synuclein (a-S) has at-
tracted most attention since a-S is a major constituent of LBs
[1,2]. Moreover, it is now apparent that gene multiplication of
wild type (WT) a-S is responsible for familial PD with LBs [1].Abbreviations:DA, dopamine; PD, Parkinson’s disease; SN, substantia
nigra; LBs, Lewy bodies; a-S, a-synuclein; WT, wild type; AS, antis-
ense; DAQ, dopamine quinone; dopaquinone, DOQ; b-S, b-synuclein;
CAT, chloramphenicol acetyltransferase; MTT, 3-(4,5-dimethylthiazo-
2-yl)-2,5-diphenyltetrazolium bromide; DWm, mitochondrial mem-
brane potential; HMW, high molecular weight
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doi:10.1016/j.febslet.2006.03.018Several lines of evidence have shown that a prerequisite of a-
S pathology is its oligomerization into cytotoxic protoﬁbrils,
followed by the formation of insoluble ﬁbrils [1,3]. Unfortu-
nately, to date, the exact pathophysiological processes by which
a-S plays a role in PD still remains to be elucidated. More spe-
ciﬁcally, since a-S is ubiquitously expressed at high levels in all
brain regions [4], the mechanisms responsible for the selective
neurodegeneration of dopaminergic neurons in the substantia
nigra remain to be determined. Previous evidence indicates that
the speciﬁc vulnerability of dopaminergic neurons may be
linked to the cytotoxic oxidative potential of dopamine (DA)
itself [5,6]. Notably, overexpression of WT or A53T mutant
a-S causes death of dopaminergic neurons in mesencephalic
culture [7] and also a-S may regulate DA biosynthesis by inter-
action with the tyrosine hydroxylase [8]. Furthermore, it has
been reported that a-S may regulate the function of the DA
transporter and vesicular monoamine transporter [9]. There-
fore, the pathological metabolism of a-S may be closely linked
to the misregulation of DA, consequently leading to neuronal
death. In support of such a notion, DA or DOPA-derived
orthoquinone (DAQ, DOQ) accelerates and stabilizes the for-
mation of cytotoxic a-S protoﬁbrils [10,11].
To elucidate the pathophysiological mechanisms underlying
a-S-mediated neurodegeneration in DA neurons, we developed
novel neuronal cell lines co-expressing a-S (WT or A53T) and
tyrosinase. Tyrosinase, a key enzyme in the biosynthesis of
melanin, catalyzes both the hydroxylation of tyrosine to L-
DOPA and the subsequent oxidation of L-DOPA and DA to
their speciﬁc o-quinones [12]. Our ﬁndings show that a-S and
oxidized metabolites of catechols produced by tyrosinase facil-
itate apoptotic cell death which may be accompanied by the
formation of oligomerized a-S. Furthermore, our data indi-
cates that the mitochondrial membrane might be an initial tar-
get in the process of dopaminergic neurodegeneration.2. Materials and methods
2.1. Cell culture and transfection
In a previous study, we established SH-SY5Y cell lines (CRL-2266;
ATCC) expressing human tyrosinase under the transcriptional control
of the T-REx system (Invitrogen) [12]. In these cell lines, addition of
tetracycline to the culture media (1 lg/ml), resulting in a depression of
the cytomegalovirus promoter activity, promotes expression of the
tyrosinase encoded by pcDNA4/TO/tyrosinase. As described, we iso-
lated four independent clones which all showed essentially identical re-
sults in biochemical and histoﬂuorescence studies [12]. In this study, weblished by Elsevier B.V. All rights reserved.
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(AS) and A53T mutant a-S cDNAs [13], in addition to b-synuclein
(b-S; MGC-10445, ATCC), and chloramphenicol acetyltransferase
(CAT) cDNAs as negative control genes. These expression plasmids
were cotransfected into the TR5TY6 clone by using the DOTAP lipo-
somal transfection reagent (Roche). Polyclonal pools of stably trans-
fected cells were selected and maintained in DMEM containing 7 lg/
ml blasticidin, 300 lg/ml zeocin and 300 lg/ml hygromycin B supple-
mented with 10% FBS at 37 C under 5% CO2/air.
2.2. Cell viability assay
Cells (0.5 · 105 cells/cm2), seeded in 96-well plates, were incubated
overnight and, thereafter, cultured in DMEM with or without tetracy-
cline (1 lg/ml) for indicated periods (0–7 days). Cell survival rates were
evaluated using the 3-(4,5-dimethylthiazo-2-yl)-2,5-diphenyltetrazo-
lium bromide (MTT, Sigma) assay as described elsewhere.
2.3. Immunocytochemistry and immunoblot analyses
Immunocytochemical studies were conducted as previously de-
scribed [14], using the following primary antibodies: mouse monoclo-
nal anti-a-S (1:1000; Zymed), mouse monoclonal anti-b-S (1:1000;
BD Bioscience), mouse monoclonal anti-tyrosinase (1:2000; NeoMar-
kers), rabbit monoclonal anti-active caspase-3 (1:1000; BD Bioscience)
and rabbit polyclonal anti-cytochrome c (1:500; Santa Cruz Biotech-
nology). The nuclei were counterstained with TO-PRO-3 (Molecular
Probes). Images were analyzed with a FV300 confocal laser scanning
microscope (LSM, Olympus). Western blot analysis were performed
according to the established techniques [13].
2.4. Single-cell gel-electrophoresis assay (Comet assay)
To detect DNA damage in individual cells, we adopted a single-cell
gel-electrophoresis assay [15]. Brieﬂy, cells (2 · 104) were collected and
resuspend in 1 mL of PBS containing 0.5% low melting point agarose.
One hundred microliters of the resultant mixture was applied to slidesFig. 1. Morphology and cell viability of SH-SY5Y cells after expression o
pigmented granules are evident in the neuronal cytosol. Results are means
standard errors (B). On day 5 after tyrosinase induction, activated-caspase-3
values shown represent mean ± standard errors.) (C). Over-expression of ty
cytosol (D).and submerged in cold lysis solution [2.5 M NaCl, 0.1 M EDTA,
10 mM Tris, 1% Triton X-100 (pH 10)]. Electrophoresis was carried
out at 25 V for 30 min. After electrophoresis, slides were stained with
20 lM TO-PRO3 for 1 h. Comet tail lengths were visualized using the
LSM and 20 focal planes (25 lm thickness) merged to obtain super-
imposed images. Five randomly choosed ﬁelds (total 150–200 cells)
were observed in each experiment.2.5. NBT/glycinate redox-cycling staining
Quinoproteins and related compounds were detected by redox-cy-
cling staining [16]. In brief, whole-cell lysates were prepared and sepa-
rated by 13% SDS–PAGE gel electrophoresis. Electrophoretic transfer
was performed at 100 V for 1 h at 10 C. Bound quinonoids were de-
tected by immersing a membrane in NBT/Glycinate reagent. After
washing with 0.1 M borate buﬀer, quinoproteins were detected as spe-
ciﬁc blue-purple stains.2.6. Measurement of mitochondrial membrane potential
To evaluate the eﬀect of tyrosinase overexpression on mitochondrial
membrane potential (DWm) in a-S-overexpressing cells, we adopted a
ﬂuorescent indicator, JC-1 (10 lg/mL for 10 min, Molecular Probes)
[17]. Images were scanned by using the LSM at 256 · 256, 8 bits per
pixel resolution, background oﬀset of 0. For each time point, 20–30
cells from ﬁve randomly choosed ﬁelds were analyzed and all images
converted to TIFF format and the 527:590 nm signal ratio in each cell
calculated using Image-Pro Plus software (MediaCybernetics). The
mitochondrial data from all cells were pooled and plotted as J-aggre-
gate frequency distribution histogram.
2.7. Statistical analysis
The data from the MTT and comet assays were statistically analyzed
using multivariate analysis of variance (ANOVA) and non-parametric
Mann–Whitney U-test, respectively.f tyrosinase (A and B). After 3 days of tyrosinase induction, small
of four separate experiments performed in triplicate and plotted with
-positive cells are signiﬁcantly increased (n = 100 in each experiments,
rosinase induces time-dependent increase of cytochrome c release in
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3.1. Overexpression of tyrosinase induces apoptotic cell death in
SH-SY5Y cells
Following the induction of tyrosinase, small pigmented gran-
ules similar to neuromelanin appeared in the cytoplasm on day 3
(see Fig. 1A). Thereafter, cell growth gradually declined (see
Fig. 1B) with morphological changes including deeply pig-
mented granules in shrunken cytoplasm (see Fig. 1A, Day 5
and 7). Cells which were stably transfected with pcDNA6/TR
and pcDNA4/TO/LacZ showed neither growth retardation
nor morphological changes following the addition of
tetracycline. On day 5, activated-caspase-3-positive cells were
signiﬁcantly increased accompanied by time-dependent
accumulation of cytochrome c in neuronal cytosol (see Fig. 1C
and D).
Since previous report showed increased levels of intracellular
ROS after tyrosinase induction in this cellular model [12], we
evaluated the protective eﬀects of several antioxidants. Co-
incubation with SOD and GSH for 5 days partially improved
cell viability in a dose dependent manner up to 1000 U/mL of
SOD and 1000 lM for GSH (data not shown).
3.2. Overexpression of wild type and A53T mutant a-synuclein
enhances tyrosinase-induced cytotoxicity accompanied by
an increased rate of DNA strand breakage
To investigate the eﬀect of a-S overexpression in the pres-
ence of catechol oxidized metabolites produced by tyrosinase,Fig. 2. Immunocytochemical staining of stable transformants using anti a-S o
number of viable cells declines earlier in WT or A53T mutant a-S-overexpre
Results are means of four separate experiments performed in triplicate andwe established ﬁve stable cell lines that expressed CAT, AS,
WT, and A53T mutant a-S and b-S in TR5TY6 clones in
which the expression of tyrosinase is controlled by an exoge-
neous inducer. Fig. 2A shows the results of immunocytochem-
ical staining of stable transformants using anti a-S or b-S
monoclonal Ab on day 3 after the induction of tyrosinase. a-
S-positive intracytoplasmic inclusions were occasionally seen
adjacent to pigmented granules in WT and A53T mutant a-
S-overexpressing cells. Higher magniﬁcation images revealed
that these inclusions were located in the juxtaposition of pig-
mented granules (data not shown). Fig. 2B demonstrated that
the number of viable cells declined earlier in WT/A53T mutant
a-S-overexpressing cells compared to CAT, AS a-S, or b-S-
overexpressing cells. In accordance with the MTT assay data,
the comet tail lengths in WT/A53T mutant a-S-overexpressing
cells were signiﬁcantly longer than those in mock (CAT) trans-
fected cells on days 5 and 7 (see Fig. 3A).3.3. Formation of high molecular weight complexes of
a-synuclein by catechol oxidized metabolites
To explore DAQ-mediated a-S modiﬁcation, we investigated
whether WT and mutant a-S expressed in TR5TY6 cells could
be modiﬁed by catechol oxidized metabolites catalyzed by
tyrosinase. After tyrosinase expression, immunoblot analyses
revealed that monomer a-S band (15 kDa) gradually faded
and high molecular weight (HMW) form (about 60 kDa) of
a-S-immunoreactive protein became apparent (see Fig. 3B(a)).r b-S monoclonal Abs on day 3 after tyrosinase induction (A; a–e). The
ssing cells compared to CAT, AS a-S, or b-S-overexpressing cells (B).
plotted with standard errors.
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was also detected by the redox-cycling staining (see Fig. 3B(b)).
3.4. Tyrosinase leads to mitochondrial membrane alterations,
but not MAPK activation, preceding cell death
To shed light on the mechanism underlying the apoptotic
process of cells co-expressing a-S and tyrosinase, transformed
cell lines were cultured in media containing tetracycline for 0–
72 h. During this period, overexpression of tyrosinase did not
aﬀect the levels of ERK and JNK phosphorylation in each cell
line (data not shown). Whereas, by 72 h after the induction of
tyrosinase, a histogram showing the ratio of 527–590 nm ﬂuo-
rescence demonstrated a signiﬁcant reduction of DWm in cells
overexpressing WT and A53T mutant a-S compared to those
expressing CAT or AS a-S (see Fig. 4A and B). In pilot studies,
we already conﬁrmed that the mitochondrial membrane poten-
tials were not aﬀected by the expression of CAT, WT and
mutant a-S (data not shown).4. Discussion
In this study, we found that the induction of tyrosinase, pre-
viously found to be associated with an increased production of
cytosolic DA and ROS and formation of pigmented granules
mimicking neuromelanin in nigral cells [12], leads to time-Fig. 3. Evaluation of DNA damage by single-cell gel-electrophoresis assay (A
seen in TR5TY6/CAT and TR5TY6/A53T cells (a). The comet tail lengths in W
in CAT transfected cells on days 5 and 7 after induction of tyrosinase (b). Ea
extreme points. The number of observations in the set of data is 150–200.
expression. The a-S monomer band (15 kDa) decreases and HMW form (60 k
mutant a-S co-expressing cells on day 3. Bands of similar size (60 kDa) aredependent growth retardation with a concomitant increase of
activated caspase-3-positive cells and cytochrome c release in
neuronal cytosol (see Fig. 1). These observations correspond
with previous reports demonstrating that catecholamine
metabolites, such as 5-S-cysteinyldopamine increase in SN of
PD and induce cell damage, extensive DNA modiﬁcation
and increase in caspase-3 activity in neuronal cells [5,18].
Tyrosinase-mediated neuronal cell death was prevented by
SOD and GSH (data not shown). SOD exerts its protective
function by reducing semiquinone radical and quinone forma-
tion and similarly, GSH prevents the binding of DA quinone
to the sulfhydryl groups of cysteine [19,20]. Although SOD
and GSH do not normally get into cells, it is feasible that they
may penetrate damaged cell membrane and exert protective ef-
fect on cells. Actually, DA and other ROS induce lipid perox-
idation, change of membrane ﬂuidity, and transformation of
cell morphology [21,22]. Taken together, these ﬁndings suggest
that the neuronal cell death induced by the overexpression of
tyrosinase seems to be due to the generation of catechol-qui-
none compounds in the neuronal cytosol.
Investigating the eﬀects of WT or mutant a-S expression, we
found that the co-expression of WT and A53T mutant a-S in
tyrosinase-overexpressing cells exacerbated DNA damage
and successive apoptotic cell death compared to the cells over-
expressing CAT, AS a-S, or b-S (see Figs. 2 and 3). As shown
in Fig. 2B, the viabilities of cells overexpressing AS a-S were). Photographs demonstrate typical examples of comet tails (on day 5)
T or A53T mutant a-S co-expressing cells are signiﬁcantly longer than
ch box plot identiﬁes the middle 50% of the data, the median, and the
Fig. 3B (a) shows the results of immunoblot analyses of a-S protein
Da) of a-S-immunoreactive protein increase in WT as well as the A53T
emerged by redox-cycling staining (Fig. 3B (b)).
Fig. 4. Visualization of DWm using the ﬂuorescence indicator, JC-1. Typical examples of JC-1 ﬂuorescent images of cells after induction of tyrosinase
(A). A histogram showing the ratio of 527 to 590 nm ﬂuorescence demonstrates a signiﬁcant reduction of DWm in cells overexpressing WT and A53T
mutant a-S compared to CAT or AS a-S after 72 h of tyrosinase induction (B).
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thermore, we previously reported that the endogenous expres-
sion of a-S in SH-SY5Y cell was undetectable [14]. Thus, it was
suggested that tyrosinase-induced cell death was not dependent
on endogenous a-S in these cell lines. In addition, we previ-
ously observed that overexpression of WT and mutant a-syn-
uclein alone did not aﬀect cell viability and morphology using
the same cell lines [14]. These results were in good agreements
with a recent report demonstrating that the transient expres-
sion of tyrosinase was toxic to TH-positive neurons and
showed additive eﬀects with A53T mutant a-S toxicity [23],
although they did not conﬁrm possible conformational conver-
sions or chemical modiﬁcations of a-S by tyrosinase overex-
pression. In the present study, we further demonstrated that
both WT and A53T mutant a-S co-expressed with tyrosinase
resulted in the gradual accumulation of a-S-immunopositive
HMW complexes likely representing oligomerized forms of
a-S (Fig. 3B). We previously reported that the expression of
endogenous tyrosinase in SH-SY5Y cells was undetectable
[12]. Furthermore, the overexpression of WT and mutant a-S
alone did not induce these HMW bands and only a few, scat-
tered small aggregates were observed in these cell lines [14].
Thus, it is feasible that the appearance of a-S-positive HMW
bands could be formed under the abundant presence of oxi-
dized catechol-metabolites generated by tyrosinase induction.
Indeed, in the present study, we showed the evidence that
the HMW band detected in cell lysates might correspond to
the size of a-S tetramer and was positive for the NBT/glycinate
redox-cycling staining (see Fig. 3B) suggesting that oxidized
catechol derivatives facilitate the formation of HMW com-
plexes chemically modiﬁed by quinonoids. Since, a-S does
not contain a quinone-reactive cysteine residue, such DAQ-
a-S adducts are likely generated by radical coupling of DAQ
to tyrosine and/or nucleophilic attacks by DAQ, forming aSchiﬀ base at lysine or glycine residue of a-S [11]. Indeed, sev-
eral lines of evidence demonstrated that the function of WT a-
S was found to be cell line- and insult-speciﬁc, and WT a-S
may have both protective and non-protective properties
[7,24–26]. Some investigators speculate that the overexpression
and/or prolonged exposure of this protein in the presence of
noxious stimuli such as DA and its metabolites might become
an adverse factor [27]. On the other hand, the mutations of a-S
gene manifest not only a loss-of-function but also a situation
of gain-of-toxicity in dopaminergic neurons, and such toxicity
would become more serious when combined with environmen-
tal toxins [7,24,25,28]. Zhou et al. reported that the A53T mu-
tant a-S is twice as potent in inducing dopaminergic neuronal
death and more eﬀectively produce intracytoplasmic inclusions
compared to WT a-S [7]. However, in this study, WT and mu-
tant a-S were equally eﬀective to cause apoptotic neuronal cell
death accompanied by the formation of a-S-positive HMW
complexes and intracytoplasmic inclusions. Thus, it might be
possible that both WT and mutant a-S could equally elicit
cytotoxicity under the abundant presence of catechol-oxidized
metabolites.
Recent reports suggested that protoﬁbrillar a-S binds to li-
pid bilayers and increases membrane permeability by forming
pore-like structures [29]. While the membranous structures
damaged by protoﬁbrils remain unknown, intracellular orga-
nelle, such as synaptic vesicles and mitochondria, are possible
candidates. In this regards, disruption of synaptic vesicle mem-
branes would result in an increase of cytosolic DA levels to
trigger further accumulation of DA-quinone and DA-derived
oxyradicals and thus lead to a vicious cycle. Likewise, mito-
chondrial enzymes in the electron transport chain and the
functional permeability transition pores are impaired by DA
oxidation products [30] making it plausible that the early dam-
age of mitochondria observed in this study reﬂects actions of
2152 T. Hasegawa et al. / FEBS Letters 580 (2006) 2147–2152a-S protoﬁbrils and subsequent increase of membrane perme-
ability in the presence of oxidized catecholamine metabolites.
Although several reports indicate that DA-induced cytotoxic-
ity is elicited through ERK signal cascade and that a-S aﬀects
MAP kinase pathways [31,32], we did not observe activation of
ERK and JNK up to 72 h after tyrosinase induction (data not
shown). In fact, taken together, our data indicate that the early
reduction of DWm is synergistically mediated by a-S and DA
oxidized metabolites that ultimately results in cell death (see
Fig. 4).
In summary, the present study supports the notion that cat-
echol oxidized metabolites cause apoptotic cell death and that
this process is exacerbated by a-S. Moreover, such metabolites
might form adducts with a-S leading to a-S oligomerization,
disruption of mitochondrial membrane potential and cell
death. Our ﬁndings therefore oﬀer insights into not only the
selective nature of dopaminergic neuronal death, but also
mechanisms of cell death in PD.
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